Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Estee Lauder shares should be bought on dip, says Evercore ISI » 09:16
05/04/21
05/04
09:16
05/04/21
09:16
EL

Estee Lauder

/

+

Evercore ISI analyst…

Evercore ISI analyst Robert Ottenstein noted that Estee Lauder shares sold off after the company's Q3 sales growth of 11% missed the consensus forecast of 13%, but he believes Estee's fundamental growth story remains intact and he would be a buyer of the stock amid the dip. Ottenstein keeps an Outperform rating and $355 price target on Estee Lauder shares.

ShowHide Related Items >><<
EL Estee Lauder
/

+

EL Estee Lauder
/

+

05/04/21 DA Davidson
Estee Lauder price target raised to $367 from $348 at DA Davidson
05/04/21 JPMorgan
Estee Lauder added to Analyst Focus List after selloff at JPMorgan
05/04/21 Deutsche Bank
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank
04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

Recommendations
Estee Lauder price target raised to $367 from $348 at DA Davidson » 09:13
05/04/21
05/04
09:13
05/04/21
09:13
EL

Estee Lauder

/

+

DA Davidson analyst Linda…

DA Davidson analyst Linda Weiser raised the firm's price target on Estee Lauder to $367 from $348 and keeps a Buy rating on the shares. The company's Q3 earnings beat expectations while revenues missed slightly, and the 8% decline in the stock price represents a "buying opportunity", the analyst tells investors in a research note. Weiser adds that Estee Lauder's Q4 earnings guidance looks conservative as the company foresees a makeup "renaissance" once the world reopens.

ShowHide Related Items >><<
EL Estee Lauder
/

+

EL Estee Lauder
/

+

05/04/21 JPMorgan
Estee Lauder added to Analyst Focus List after selloff at JPMorgan
05/04/21 Deutsche Bank
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank
04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

Recommendations
Estee Lauder added to Analyst Focus List after selloff at JPMorgan » 07:33
05/04/21
05/04
07:33
05/04/21
07:33
EL

Estee Lauder

/

+

JPMorgan analyst Andrea…

JPMorgan analyst Andrea Teixeira lowered the firm's price target on Estee Lauder to $323 from $336 and keeps an Overweight rating on the shares post the company's fiscal Q3 results. The analyst also added the shares to the firm's U.S. Analyst Focus List as a growth idea. The post-earnings stock selloff yesterday presents a "unique buying opportunity for a high quality reopening story," Teixeira tells investors in a research note. While sales missed in Q3 and the recovery has not been on a straight line, the bull thesis of China reacceleration, skincare and e-commerce growth remains intact, says Teixeira.

ShowHide Related Items >><<
EL Estee Lauder
/

+

EL Estee Lauder
/

+

05/04/21 Deutsche Bank
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank
04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

Recommendations
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank » 06:55
05/04/21
05/04
06:55
05/04/21
06:55
EL

Estee Lauder

/

+

Deutsche Bank analyst…

Deutsche Bank analyst Steve Powers lowered the firm's price target on Estee Lauder to $320 from $337 and keeps a Buy rating on the shares. The "disappointment" in fiscal Q3 results stemmed largely from the lower than hoped for local currency sales growth, a miss on the gross margin line, and concerns that earnings outperformance came at the expense of brand investment, Powers tells investors in a research note. The analyst, however, remains optimistic on Estee Lauder's prospects from here, viewing the results as a "temporary speed bump."

ShowHide Related Items >><<
EL Estee Lauder
/

+

EL Estee Lauder
/

+

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

EL Estee Lauder
/

+

On The Fly
Fly Intel: Wall Street's top stories for Monday » 17:01
05/03/21
05/03
17:01
05/03/21
17:01
VZ

Verizon

$57.93 /

+0.11 (+0.19%)

, APO

Apollo Global

$55.07 /

-0.33 (-0.60%)

, GTN

Gray Television

$22.17 /

+1.85 (+9.10%)

, MDP

Meredith

$35.28 /

+4.1799 (+13.44%)

, BRK.B

Berkshire Hathaway

$279.23 /

+4.62 (+1.68%)

, BRK.A

Berkshire Hathaway

$420,000.00 /

+7500 (+1.82%)

, EL

Estee Lauder

$288.93 /

-25.07 (-7.98%)

, AMZN

Amazon.com

$3,387.95 /

-77.79 (-2.24%)

, OCGN

Ocugen

$15.67 /

+3.03 (+23.97%)

, BNTX

BioNTech

$209.00 /

+20.61 (+10.94%)

, PFE

Pfizer

$39.83 /

+1.17 (+3.03%)

, VXRT

Vaxart

$8.01 /

-2.78 (-25.76%)

, NVAX

Novavax

$195.10 /

-41.69 (-17.61%)

The major averages had a…

ShowHide Related Items >><<
VZ Verizon
$57.93 /

+0.11 (+0.19%)

VXRT Vaxart
$8.01 /

-2.78 (-25.76%)

OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

NVAX Novavax
$195.10 /

-41.69 (-17.61%)

MDP Meredith
$35.28 /

+4.1799 (+13.44%)

GTN Gray Television
$22.17 /

+1.85 (+9.10%)

EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

BRK.B Berkshire Hathaway
$279.23 /

+4.62 (+1.68%)

BNTX BioNTech
$209.00 /

+20.61 (+10.94%)

APO Apollo Global
$55.07 /

-0.33 (-0.60%)

AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

VZ Verizon
$57.93 /

+0.11 (+0.19%)

04/27/21
Fly Intel: Top five analyst downgrades
04/27/21 MoffettNathanson
Verizon downgraded to Neutral from Buy at MoffettNathanson
04/27/21 MoffettNathanson
Verizon downgraded to Neutral from Buy at MoffettNathanson
04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
APO Apollo Global
$55.07 /

-0.33 (-0.60%)

04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform from Perform at Oppenheimer
GTN Gray Television
$22.17 /

+1.85 (+9.10%)

05/03/21 Barrington
Gray creates added scale with Meredith's broadcast assets, says Barrington
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/05/21 Loop Capital
Gray Television price target raised to $25 from $23 at Loop Capital
10/15/20 Loop Capital
Gray Television initiated with a Buy at Loop Capital
MDP Meredith
$35.28 /

+4.1799 (+13.44%)

03/01/21 Benchmark
Meredith upgraded to Buy from Hold at Benchmark
02/09/21 Citi
Meredith price target raised to $28 from $21 at Citi
08/14/20
Fly Intel: Top five analyst downgrades
BRK.B Berkshire Hathaway
$279.23 /

+4.62 (+1.68%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$420,000.00 /

+7500 (+1.82%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

05/04/21 JPMorgan
Estee Lauder added to Analyst Focus List after selloff at JPMorgan
05/04/21 Deutsche Bank
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank
04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
04/30/21 Truist
Amazon.com price target raised to $4,000 from $3,750 at Truist
OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

04/21/21 Roth Capital
EUA submission to follow after Ocugen partner COVAXIN results, says Roth Capital
03/31/21
Ocugen participates in a conference call with Cantor Fitzgerald
03/16/21 Roth Capital
Covaxin chances of U.S. approval now increased, says Roth Capital
03/04/21 Roth Capital
Ocugen price target raised to $10 from $9 at Roth Capital
BNTX BioNTech
$209.00 /

+20.61 (+10.94%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.83 /

+1.17 (+3.03%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
VXRT Vaxart
$8.01 /

-2.78 (-25.76%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
NVAX Novavax
$195.10 /

-41.69 (-17.61%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
VZ Verizon
$57.93 /

+0.11 (+0.19%)

VXRT Vaxart
$8.01 /

-2.78 (-25.76%)

PFE Pfizer
$39.83 /

+1.17 (+3.03%)

OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

NVAX Novavax
$195.10 /

-41.69 (-17.61%)

MDP Meredith
$35.28 /

+4.1799 (+13.44%)

GTN Gray Television
$22.17 /

+1.85 (+9.10%)

EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

BRK.B Berkshire Hathaway
$279.23 /

+4.62 (+1.68%)

BRK.A Berkshire Hathaway
$420,000.00 /

+7500 (+1.82%)

APO Apollo Global
$55.07 /

-0.33 (-0.60%)

AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

  • 23
    Jul
VZ Verizon
$57.93 /

+0.11 (+0.19%)

PFE Pfizer
$39.83 /

+1.17 (+3.03%)

OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

NVAX Novavax
$195.10 /

-41.69 (-17.61%)

MDP Meredith
$35.28 /

+4.1799 (+13.44%)

EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

BRK.B Berkshire Hathaway
$279.23 /

+4.62 (+1.68%)

BRK.A Berkshire Hathaway
$420,000.00 /

+7500 (+1.82%)

BNTX BioNTech
$209.00 /

+20.61 (+10.94%)

APO Apollo Global
$55.07 /

-0.33 (-0.60%)

AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

VZ Verizon
$57.93 /

+0.11 (+0.19%)

VXRT Vaxart
$8.01 /

-2.78 (-25.76%)

OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

NVAX Novavax
$195.10 /

-41.69 (-17.61%)

MDP Meredith
$35.28 /

+4.1799 (+13.44%)

EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

BRK.B Berkshire Hathaway
$279.23 /

+4.62 (+1.68%)

APO Apollo Global
$55.07 /

-0.33 (-0.60%)

AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

VZ Verizon
$57.93 /

+0.11 (+0.19%)

VXRT Vaxart
$8.01 /

-2.78 (-25.76%)

PFE Pfizer
$39.83 /

+1.17 (+3.03%)

OCGN Ocugen
$15.67 /

+3.03 (+23.97%)

NVAX Novavax
$195.10 /

-41.69 (-17.61%)

EL Estee Lauder
$288.93 /

-25.07 (-7.98%)

BNTX BioNTech
$209.00 /

+20.61 (+10.94%)

APO Apollo Global
$55.07 /

-0.33 (-0.60%)

AMZN Amazon.com
$3,387.95 /

-77.79 (-2.24%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:12
05/03/21
05/03
12:12
05/03/21
12:12
VZ

Verizon

$58.26 /

+0.44 (+0.76%)

, APO

Apollo Global

$55.57 /

+0.17 (+0.31%)

, GTN

Gray Television

$22.59 /

+2.27 (+11.17%)

, MDP

Meredith

$32.62 /

+1.52 (+4.89%)

, BRK.B

Berkshire Hathaway

$280.30 /

+5.69 (+2.07%)

, BRK.A

Berkshire Hathaway

$420,500.00 /

+8000 (+1.94%)

, EL

Estee Lauder

$290.59 /

-23.41 (-7.46%)

, OCGN

Ocugen

$15.30 /

+2.66 (+21.04%)

, BNTX

BioNTech

$207.10 /

+18.71 (+9.93%)

, PFE

Pfizer

$39.61 /

+0.945 (+2.44%)

, VXRT

Vaxart

$9.02 /

-1.775 (-16.45%)

, NVAX

Novavax

$204.76 /

-32.03 (-13.53%)

The major averages are…

ShowHide Related Items >><<
VZ Verizon
$58.26 /

+0.44 (+0.76%)

VXRT Vaxart
$9.02 /

-1.775 (-16.45%)

OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

NVAX Novavax
$204.76 /

-32.03 (-13.53%)

MDP Meredith
$32.62 /

+1.52 (+4.89%)

GTN Gray Television
$22.59 /

+2.27 (+11.17%)

EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

BRK.B Berkshire Hathaway
$280.30 /

+5.69 (+2.07%)

BNTX BioNTech
$207.10 /

+18.71 (+9.93%)

APO Apollo Global
$55.57 /

+0.17 (+0.31%)

VZ Verizon
$58.26 /

+0.44 (+0.76%)

04/27/21
Fly Intel: Top five analyst downgrades
04/27/21 MoffettNathanson
Verizon downgraded to Neutral from Buy at MoffettNathanson
04/27/21 MoffettNathanson
Verizon downgraded to Neutral from Buy at MoffettNathanson
04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
APO Apollo Global
$55.57 /

+0.17 (+0.31%)

04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform from Perform at Oppenheimer
GTN Gray Television
$22.59 /

+2.27 (+11.17%)

05/03/21 Barrington
Gray creates added scale with Meredith's broadcast assets, says Barrington
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/05/21 Loop Capital
Gray Television price target raised to $25 from $23 at Loop Capital
10/15/20 Loop Capital
Gray Television initiated with a Buy at Loop Capital
MDP Meredith
$32.62 /

+1.52 (+4.89%)

03/01/21 Benchmark
Meredith upgraded to Buy from Hold at Benchmark
02/09/21 Citi
Meredith price target raised to $28 from $21 at Citi
08/14/20
Fly Intel: Top five analyst downgrades
BRK.B Berkshire Hathaway
$280.30 /

+5.69 (+2.07%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$420,500.00 /

+8000 (+1.94%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

04/21/21 Roth Capital
EUA submission to follow after Ocugen partner COVAXIN results, says Roth Capital
03/31/21
Ocugen participates in a conference call with Cantor Fitzgerald
03/16/21 Roth Capital
Covaxin chances of U.S. approval now increased, says Roth Capital
03/04/21 Roth Capital
Ocugen price target raised to $10 from $9 at Roth Capital
BNTX BioNTech
$207.10 /

+18.71 (+9.93%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.61 /

+0.945 (+2.44%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
VXRT Vaxart
$9.02 /

-1.775 (-16.45%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
NVAX Novavax
$204.76 /

-32.03 (-13.53%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
VZ Verizon
$58.26 /

+0.44 (+0.76%)

VXRT Vaxart
$9.02 /

-1.775 (-16.45%)

PFE Pfizer
$39.61 /

+0.945 (+2.44%)

OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

NVAX Novavax
$204.76 /

-32.03 (-13.53%)

MDP Meredith
$32.62 /

+1.52 (+4.89%)

GTN Gray Television
$22.59 /

+2.27 (+11.17%)

EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

BRK.B Berkshire Hathaway
$280.30 /

+5.69 (+2.07%)

BRK.A Berkshire Hathaway
$420,500.00 /

+8000 (+1.94%)

APO Apollo Global
$55.57 /

+0.17 (+0.31%)

  • 23
    Jul
VZ Verizon
$58.26 /

+0.44 (+0.76%)

PFE Pfizer
$39.61 /

+0.945 (+2.44%)

OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

NVAX Novavax
$204.76 /

-32.03 (-13.53%)

MDP Meredith
$32.62 /

+1.52 (+4.89%)

EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

BRK.B Berkshire Hathaway
$280.30 /

+5.69 (+2.07%)

BRK.A Berkshire Hathaway
$420,500.00 /

+8000 (+1.94%)

BNTX BioNTech
$207.10 /

+18.71 (+9.93%)

APO Apollo Global
$55.57 /

+0.17 (+0.31%)

VZ Verizon
$58.26 /

+0.44 (+0.76%)

VXRT Vaxart
$9.02 /

-1.775 (-16.45%)

PFE Pfizer
$39.61 /

+0.945 (+2.44%)

OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

NVAX Novavax
$204.76 /

-32.03 (-13.53%)

MDP Meredith
$32.62 /

+1.52 (+4.89%)

EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

BRK.B Berkshire Hathaway
$280.30 /

+5.69 (+2.07%)

BRK.A Berkshire Hathaway
$420,500.00 /

+8000 (+1.94%)

BNTX BioNTech
$207.10 /

+18.71 (+9.93%)

APO Apollo Global
$55.57 /

+0.17 (+0.31%)

VZ Verizon
$58.26 /

+0.44 (+0.76%)

VXRT Vaxart
$9.02 /

-1.775 (-16.45%)

PFE Pfizer
$39.61 /

+0.945 (+2.44%)

OCGN Ocugen
$15.30 /

+2.66 (+21.04%)

NVAX Novavax
$204.76 /

-32.03 (-13.53%)

EL Estee Lauder
$290.59 /

-23.41 (-7.46%)

BNTX BioNTech
$207.10 /

+18.71 (+9.93%)

APO Apollo Global
$55.57 /

+0.17 (+0.31%)

Hot Stocks
Estee Lauder falls -4.8% » 10:00
05/03/21
05/03
10:00
05/03/21
10:00
EL

Estee Lauder

$298.97 /

-15.03 (-4.79%)

Estee Lauder is down…

Estee Lauder is down -4.8%, or -$15.08 to $298.72.

ShowHide Related Items >><<
EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

EL Estee Lauder
$298.97 /

-15.03 (-4.79%)

Hot Stocks
Estee Lauder falls -4.1% » 09:47
05/03/21
05/03
09:47
05/03/21
09:47
EL

Estee Lauder

$301.43 /

-12.57 (-4.00%)

Estee Lauder is down…

Estee Lauder is down -4.1%, or -$12.72 to $301.08.

ShowHide Related Items >><<
EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

EL Estee Lauder
$301.43 /

-12.57 (-4.00%)

On The Fly
Fly Intel: Pre-market Movers » 08:58
05/03/21
05/03
08:58
05/03/21
08:58
FOLD

Amicus

$9.83 /

-0.14 (-1.40%)

, BTX

Brooklyn ImmunoTherapeutics

$49.44 /

+15.96 (+47.67%)

, BRK.B

Berkshire Hathaway

$274.61 /

-3.12 (-1.12%)

, BRK.A

Berkshire Hathaway

$412,500.00 /

-4480 (-1.07%)

, EPD

Enterprise Products

$23.01 /

-0.42 (-1.79%)

, CRNT

Ceragon Networks

$3.40 /

-0.135 (-3.82%)

, AKTS

Akoustis

$11.22 /

-0.99 (-8.11%)

, LDI

LoanDepot

$19.87 /

+0.052 (+0.26%)

, ENBL

Enable Midstream

$7.41 /

-0.155 (-2.05%)

, EL

Estee Lauder

$314.00 /

-2.57 (-0.81%)

, PETS

PetMed Express

$29.39 /

-0.07 (-0.24%)

, CLX

Clorox

$182.29 /

-3.79 (-2.04%)

, VXRT

Vaxart

$10.79 /

+1.58 (+17.16%)

Check out this morning's…

ShowHide Related Items >><<
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BTX Brooklyn ImmunoTherapeutics
$49.44 /

+15.96 (+47.67%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/14/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
04/13/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
03/01/21 Stifel
Amicus initiated with a Hold at Stifel
BTX Brooklyn ImmunoTherapeutics
$49.44 /

+15.96 (+47.67%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

04/06/21 TD Securities
Enterprise Products initiated with a Buy at TD Securities
01/20/21 Mizuho
Enterprise Products price target raised to $27 from $24 at Mizuho
12/03/20 SMBC Nikko
Enterprise Products initiated with an Outperform at SMBC Nikko
11/23/20 Wolfe Research
Enterprise Products upgraded to Outperform from Peer Perform at Wolfe Research
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

03/30/21 Roth Capital
Akoustis secures WiFi 6e reference design win, says Roth Capital
02/23/21 Roth Capital
Akoustis equity financing improves balance sheet, says Roth Capital
02/02/21 Lake Street
Akoustis price target raised to $19 from $10 at Lake Street
02/01/21 Roth Capital
Akoustis price target raised to $25 from $16 at Roth Capital
LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

04/21/21 Barclays
LoanDepot downgraded to Equal Weight from Overweight at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
03/26/21 Credit Suisse
Credit Suisse lowers estimates on mortgage originators
03/09/21 William Blair
LoanDepot initiated with an Outperform at William Blair
ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

03/02/21 Barclays
Enable Midstream upgraded to Equal Weight from Underweight at Barclays
03/01/21 Mizuho
Enable Midstream downgraded to Neutral from Buy at Mizuho
11/16/20 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
10/26/20 Mizuho
CenterPoint Energy price target raised to $25 from $20 at Mizuho
EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

03/05/21 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
01/27/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
08/19/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
CLX Clorox
$182.29 /

-3.79 (-2.04%)

05/03/21 Credit Suisse
Clorox price target lowered to $185 from $205 at Credit Suisse
05/03/21 Wells Fargo
Clorox downgraded to Underweight from Overweight at Wells Fargo
05/03/21 Deutsche Bank
Clorox price target lowered to $186 from $195 at Deutsche Bank
04/16/21 JPMorgan
Clorox price target lowered to $196 from $205 at JPMorgan
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

  • 11
    Feb
FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

Hot Stocks
Estee Lauder CEO says 'sales rose in every region' in Q3 » 06:50
05/03/21
05/03
06:50
05/03/21
06:50
EL

Estee Lauder

$314.00 /

-2.57 (-0.81%)

Fabrizio Freda, President…

Fabrizio Freda, President and CEO said, "We exceeded our sales and earnings expectations, even as several markets experienced increasing pressure from COVID-19 throughout the quarter. Our growth engines of Skin Care and Fragrance were incredibly powerful. Sales rose in every region, led by double-digit growth in Asia/Pacific, where many markets contributed and sales growth in mainland China accelerated. Online thrived as a growth engine, with sales having increased strong double-digits around the world, and Travel Retail excelled. Estee Lauder, La Mer, Jo Malone London, Clinique, and Tom Ford Beauty led the robust performance of many brands in our portfolio. Our fiscal year-to-date sales and adjusted operating margin exceed that of the same period in fiscal 2019, as we continue to successfully navigate the challenges of the pandemic. With strong cash flow generation, we resumed share repurchases in the third quarter. We are thrilled to have agreed to increase our ownership in DECIEM, becoming majority owners with a path to full ownership in three years. DECIEM's soaring brand The Ordinary and new brand incubation capability further enhance our superior multiple engines of growth strategy." Freda emphasized "We have achieved these outstanding results while, first and foremost, caring for the safety and well-being of our employees and consumers amid the pandemic. Impressively, we are investing in many compelling long-term growth drivers, including end-to-end innovation with a new center in Shanghai, state of the art manufacturing in Asia/Pacific, global online, and consumer analytics. We are progressing on our environmental goals and acting on our social commitments with urgency. We expect the momentum in our sales growth to build in the fourth quarter of fiscal 2021, not only from easing comparisons but also fundamental strength, as we drive recovery."

ShowHide Related Items >><<
EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.